Dr. Xavier F. Jimenez, MD

Dr. Jimenez practices at Zucker Hillside Hospital - Methadone Clinic - Unit in Glen Oaks, New York.

Dr. Jimenez's NPI, 1881907756, was assigned on July 21, 2010. Dr. Jimenez graduated from Ross University School of Medicine in 2008. Dr. Jimenez holds Pennsylvania license MT197696.

Dr. Jimenez's primary practice is Zucker Hillside Hospital - Methadone Clinic - Unit, at 75-59 263rd St, Glen Oaks, NY 11004.

Dr. Jimenez's primary practice is Zucker Hillside Hospital - Methadone Clinic - Unit in Glen Oaks, New York. Dr. Jimenez is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Jimenez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jimenez practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Jimenez's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Jimenez is licensed in Pennsylvania.

CMS data shows 462 Medicare services from Dr. Jimenez across 2 procedure codes in 2024, for 189 Medicare patients. Medicare paid $40,263 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 189 Medicare patients who saw Dr. Jimenez in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jimenez's median patient age at 67, with 43% women.

In 2024, Dr. Jimenez wrote 166 Medicare Part D claims. 92% of them were for generic drugs. CMS names the drug for 118 of them, across 8 drugs with 11 or more claims each, at $4,810 in total drug cost. In 2023, CMS named 86 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Jimenez for performance year 2024, reported through an alternative payment model (APM). Dr. Jimenez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 43 general payments to Dr. Jimenez from 4 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Abbvie Inc. paid the most, $3,574.

Dr. Jimenez graduated from Ross University School of Medicine in 2008.